EFFECTS OF AMLODIPINE ON 24-HOUR AMBULATORY BLOOD-PRESSURE PROFILES, ELECTROCARDIOGRAPHIC MONITORING, AND LEFT-VENTRICULAR MASS AND FUNCTION IN BLACK PATIENTS WITH VERY SEVERE HYPERTENSION
J. Skoularigis et al., EFFECTS OF AMLODIPINE ON 24-HOUR AMBULATORY BLOOD-PRESSURE PROFILES, ELECTROCARDIOGRAPHIC MONITORING, AND LEFT-VENTRICULAR MASS AND FUNCTION IN BLACK PATIENTS WITH VERY SEVERE HYPERTENSION, Journal of clinical pharmacology, 35(11), 1995, pp. 1052-1059
In a 3-month, open-label study, 54 consecutive black patients with ver
y severe hypertension were treated with amlodipine. Very severe hypert
ension was defined as an average sitting diastolic blood pressure (BP)
greater than or equal to 115 mmHg and less than or equal to 140 mmHg
as a mean of 10 readings over a 30-minute period using an automatic BP
measuring device and a mean 24-hour diastolic ambulatory blood pressu
re (ABP) greater than or equal to 110 mmHg and less than or equal to 1
40 mmHg). Serial changes in 24-hour ABP and electrocardiographic monit
oring, left ventricular (LV) mass index, and LV systolic function were
evaluated. Mean 24-hour ABP was reduced from 181 +/- 14/119 +/- 6 to
140 +/- 15/92 +/- 9 mmHg at 3 months (P < 0.0001). Target BP (mean 24-
hour diastolic ABP <90 mmHg) was achieved in 35% of the patients. The
reduction in BP was sustained for 24 hours after drug administration.
Simultaneous BP measurements using the automatic BP measuring device w
ere significantly different from the ABP measurements before and after
treatment, suggesting a marked ''white coat'' presser effect. At base
line, frequent or complex ventricular arrhythmias (>30 ventricular ext
rasystoles per hour, ventricular couplets) were present in 2 (4%) pati
ents, with no significant change after treatment. Left ventricular mas
s index regressed from 140 +/- 50 to 111 +/- 30 g/m(2) at 3 months (P
< 0.03); LV performance was not adversely affected, Adverse effects we
re few and tended to disappear during the treatment period. All of the
clinical laboratory parameters tested remained unchanged. In this gro
up of patients, treatment with amlodipine showed a marked and sustaine
d antihypertensive action as demonstrated by 24-hour ABP monitoring, a
nd was well tolerated and associated with LV mass regression without a
dverse effect on systolic cardiac function, Further, a low rate of com
plex ventricular arrhythmias was documented.